Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
about
Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis controlNew Japanese encephalitis vaccines: alternatives to production in mouse brain.The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic reviewComparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.Control of Japanese encephalitis in Asia: the time is nowCellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.IC51 Japanese encephalitis vaccine.IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.
P2860
Q33692361-B1867BC1-39F4-4157-B5FB-A83678A718BCQ33768573-F11689C5-A62C-4832-A0C2-353D28AE8BB0Q34173039-11BC2FF3-5072-448C-A27D-980861E53866Q35553715-D2934F14-17AC-4C87-BB1B-CE9C5840D45CQ35558900-A7FD07D6-FA53-475F-9EAD-EB7B631BD055Q35886942-95BED87C-57EE-45C2-87CF-FF57B4642A4AQ36125852-E5120759-C0A8-44A9-A7A0-A1F22E0CAE9BQ36263779-56DD101A-EFC9-4CFE-9DA8-F5D09B29F35EQ36871954-DBDADBF7-ABE7-4849-B8AE-82091ED9C661Q37336762-4B60FBED-F69B-4ECF-B0CD-AC19AD973FFBQ37407873-C342FD43-D4B8-4071-8B68-194D10F2C47CQ37519659-4459C9F3-C586-458C-89BA-4C7071918D53Q37812123-B75DC036-2BCD-4B71-BD1B-9D7CBB49479BQ38608325-C0489B86-E914-4E30-8776-28DC1431AC56
P2860
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of the immunogenici ...... vaccine in Philippine infants.
@en
Comparison of the immunogenici ...... vaccine in Philippine infants.
@nl
type
label
Comparison of the immunogenici ...... vaccine in Philippine infants.
@en
Comparison of the immunogenici ...... vaccine in Philippine infants.
@nl
prefLabel
Comparison of the immunogenici ...... vaccine in Philippine infants.
@en
Comparison of the immunogenici ...... vaccine in Philippine infants.
@nl
P2093
P921
P1433
P1476
Comparison of the immunogenici ...... vaccine in Philippine infants.
@en
P2093
Benli Zhou
Julie Jacobson
Kathleen M Neuzil
Mansour Yaïch
Salvacion Gatchalian
Sutee Yoksan
P304
P356
10.1016/J.VACCINE.2008.02.042
P407
P577
2008-03-18T00:00:00Z